![Timothy Keutzer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Timothy Keutzer
Chief Operating Officer at
SPERO THERAPEUTICS, INC.
Net worth: 405 512 $ as of 30/09/2026
Profile
Timothy Keutzer is currently Chief Operating Officer at Spero Therapeutics, Inc. since 2023.
Formerly, Mr. Keutzer was Vice President-Program & Portfolio Management at Cubist Pharmaceuticals LLC from 2014 to 2015.
Mr. Keutzer completed undergraduate education at the University of Kentucky.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 01/04/2026 | 335,134 ( 0.58% ) | 405 512 $ | 30/09/2026 |
Timothy Keutzer active positions
| Companies | Position | Start |
|---|---|---|
| SPERO THERAPEUTICS, INC. | Chief Operating Officer | 01/02/2023 |
Former positions of Timothy Keutzer
| Companies | Position | End |
|---|---|---|
| CUBIST PHARMACEUTICALS INC | Corporate Officer/Principal | 01/07/2015 |
Education of Timothy Keutzer
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
49
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Cubist Pharmaceuticals LLC
 Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Develops antibiotics to combat drug-resistant bacterial infections | Health Technology |
University of Kentucky
 University of Kentucky Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spero Therapeutics, Inc.
 Spero Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of bacterial infections | Health Technology |
- Stock Market
- Insiders
- Timothy Keutzer
